Is There a Once a Month Weight Loss Injection? Here's the Honest Answer

Why do people assume there's a monthly injection for weight loss?

It's a very reasonable assumption. Long-acting injectable medicines exist in other areas of medicine, some contraceptives and certain antipsychotics are given monthly or even quarterly. The idea of a single injection covering four weeks has obvious practical appeal, and it's probably why this search is so common.

With weight management injections, the science currently lands on once-weekly dosing. Both Mounjaro and Wegovy are designed to maintain a steady concentration in the body over seven days. That weekly rhythm is built into how they work, not an inconvenience the manufacturers haven't got round to fixing. Research into longer-acting formulations is ongoing, but as of summer 2026 no monthly weight loss injection has received MHRA approval for use in the UK.

One practical detail that often gets missed: each Mounjaro KwikPen contains four weekly doses. So while you're injecting once a week, you're typically ordering and receiving treatment once a month. For many people that's close enough to the convenience they were looking for. The injection itself takes seconds; the pen lives in your fridge between uses.

How do these weekly injections actually work in the body?

Mounjaro (tirzepatide) activates two gut-hormone receptors, GIP and GLP-1, that are involved in appetite regulation and blood-sugar control. Wegovy (semaglutide) works on the GLP-1 receptor alone. Both slow how quickly the stomach empties and increase the sense of fullness after eating, which tends to reduce how much people want to eat without requiring constant conscious effort.

The NHS medicines page for tirzepatide explains the mechanism clearly if you want a plain-language breakdown. What matters practically is that neither medicine produces an overnight result. Treatment starts at a low dose (2.5mg for Mounjaro, 0.25mg for Wegovy) and the prescriber increases it gradually over several months. The starter dose is there to give your system time to adjust, not to deliver the full effect.

In clinical trials, participants using tirzepatide at the highest dose lost an average of around 20–21% of their body weight over 72 weeks, as reported in the SURMOUNT-1 trial. Semaglutide 2.4mg produced average losses of around 15% over 68 weeks in the STEP 1 trial. If you're curious how the two compare, it's worth reading about once-a-week weight loss injections in more detail, and you can also find out more about once-a-day weight loss injection options if you're wondering whether any daily alternatives exist.

Who can actually be prescribed these injections?

Both medicines are licensed for adults. The eligibility criteria follow the licensed indications set out in each medicine's summary of product characteristics. Broadly: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance.

BMI is the starting point, not the whole picture. A prescriber also looks at your medical history, any medicines you're taking, and conditions that might mean these treatments aren't appropriate, a history of certain thyroid conditions or pancreatitis, for example. Pregnancy, breastfeeding, and trying to conceive are situations where neither medicine is recommended. These treatments aren't licensed for under-18s either.

A question our prescribers hear regularly is whether someone who's tried other routes before qualifies. The answer depends on the individual assessment, not a blanket rule. If you've already been on treatment elsewhere and want to continue, you can explore what a longer supply of weight loss injections looks like through a regulated service. Transfer patients are reviewed on the same clinical basis as new patients, evidence of current treatment and dose history is part of that.

Understanding how medical weight management works in practice can help set realistic expectations before a consultation. These are tools that work alongside changes to diet and activity, not instead of them.

What are the common side effects worth knowing before you start?

Most side effects are gastrointestinal. Nausea is the most frequently reported, followed by changes in bowel habits, indigestion, burping and fatigue. These tend to be most noticeable in the first few days after a new dose, and they usually settle. If you're considering whether taking weight loss injections for a month is enough time to judge how your body responds, starting at a low dose and titrating slowly is precisely what reduces their impact, it's not the prescriber being overly cautious, it's how the medicine is designed to be used.

There are symptoms that need prompt medical attention. Severe, persistent stomach pain that radiates to the back (with or without vomiting) can be a sign of pancreatitis, which the MHRA flagged as a known but infrequent risk in a Drug Safety Update published in January 2026. Signs of an allergic reaction, significant dehydration from prolonged vomiting or diarrhoea, and gallbladder symptoms are others to act on rather than wait out.

If you want to report a suspected side effect, the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is the right place. It's also where you can flag suspect sellers, which matters given the volume of counterfeit pens circulating online. You can read more about how to buy weight loss injections safely and what to check before trusting any online source.

If after reading all of this you're feeling a mixture of cautious interest and mild information overload, that's normal. There's a lot to take in. The right next step is a conversation with a prescriber who can answer questions specific to your situation, rather than trying to work out every detail in advance. If you'd like that conversation, start your free consultation and a GPhC-registered prescriber at our pharmacy will review your answers the same day.